Liu, Y.; Yu, S.; Xu, T.; Bodenko, V.; Orlova, A.; Oroujeni, M.; Rinne, S.S.; Tolmachev, V.; Vorobyeva, A.; Gräslund, T.
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT. Pharmaceutics 2022, 14, 1475.
https://doi.org/10.3390/pharmaceutics14071475
AMA Style
Liu Y, Yu S, Xu T, Bodenko V, Orlova A, Oroujeni M, Rinne SS, Tolmachev V, Vorobyeva A, Gräslund T.
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT. Pharmaceutics. 2022; 14(7):1475.
https://doi.org/10.3390/pharmaceutics14071475
Chicago/Turabian Style
Liu, Yongsheng, Shengze Yu, Tianqi Xu, Vitalina Bodenko, Anna Orlova, Maryam Oroujeni, Sara S. Rinne, Vladimir Tolmachev, Anzhelika Vorobyeva, and Torbjörn Gräslund.
2022. "Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT" Pharmaceutics 14, no. 7: 1475.
https://doi.org/10.3390/pharmaceutics14071475
APA Style
Liu, Y., Yu, S., Xu, T., Bodenko, V., Orlova, A., Oroujeni, M., Rinne, S. S., Tolmachev, V., Vorobyeva, A., & Gräslund, T.
(2022). Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT. Pharmaceutics, 14(7), 1475.
https://doi.org/10.3390/pharmaceutics14071475
